Ajanta Pharma informs about disclosures
Date: 03-07-2026Ajanta Pharma has informed that the Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship.
The above information is a part of company’s filings submitted to BSE.